These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6105774)

  • 1. Kainic acid and neurotransmitter interactions in the basal ganglia.
    McGeer PL; McGeer EG; Innanen VT
    Adv Biochem Psychopharmacol; 1980; 24():185-91. PubMed ID: 6105774
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistence of beta-adrenergic receptors in rat striatum following kainic acid administration.
    Zahniser NR; Minneman KP; Molinoff PB
    Brain Res; 1979 Dec; 178(2-3):589-95. PubMed ID: 228797
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution and release of GABA in the basal ganglia.
    Korf J; van der Heyden JA; Venema K; Postema F
    Adv Biochem Psychopharmacol; 1981; 30():105-17. PubMed ID: 7331934
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kainic acid: an agent for studying the brain].
    Sytinskiĭ IA; Turovskiĭ VS
    Usp Sovrem Biol; 1982; 93(2):253-69. PubMed ID: 7048784
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of chronic striatal kainate lesions on some dopaminergic parameters and enkephalin immunoreactive neurons in the basal ganglia.
    Schwarcz R; Fuxe K; Hökfelt T; Terenius L; Goldstein M
    J Neurochem; 1980 Apr; 34(4):772-8. PubMed ID: 6102111
    [No Abstract]   [Full Text] [Related]  

  • 6. [Toxic action of kainic acid as a model of Huntington chorea and epilepsy (review)].
    Levin SL; Sytinskiĭ IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(5):754-63. PubMed ID: 6224382
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrastriatal kainic acid: acute effects on electrophysiological and biochemical measures of nigrostriatal dopaminergic activity.
    Braszko JJ; Bannon MJ; Bunney BS; Roth RH
    J Pharmacol Exp Ther; 1981 Feb; 216(2):289-93. PubMed ID: 6257886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of dopaminergic neurons of the substantia nigra following lesions of the neostriatum by kainic acid].
    Doudet D; Gross C; Bioulac B
    C R Seances Soc Biol Fil; 1984; 178(3):298-306. PubMed ID: 6238656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of kainic acid injection into the substantia nigra on the paroxysmal amygdaloid phenomena].
    Crescimanno G; Benigno A
    Boll Soc Ital Biol Sper; 1984 Feb; 60(2):369-74. PubMed ID: 6712797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the source of GABA-containing terminals in the substantia nigra. Electron microscopic autoradiographic and biochemical studies.
    Hattori T; McGeer PL; Fibiger HC; McGeer EG
    Brain Res; 1973 May; 54():103-14. PubMed ID: 4350810
    [No Abstract]   [Full Text] [Related]  

  • 11. Tremor: role of striatal cholinergic neurons and the effect of intrastriatal kainic acid.
    Silbergeld EK; Hruska RE
    Neurosci Lett; 1979 Dec; 15(2-3):235-42. PubMed ID: 530529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals.
    Björklund A; Lindvall O
    Brain Res; 1975 Jan; 83(3):531-7. PubMed ID: 1111820
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute effects of the neurotoxin kainic acid on neurons of the pigeon basal ganglia. Electrophysiological and light and electron microscopic observations.
    Rieke GK; Bowers DE
    Acta Neuropathol; 1982; 56(2):123-35. PubMed ID: 7064661
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
    Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
    J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo release of transmitters in the cat basal ganglia.
    Glowinski J
    Fed Proc; 1981 Feb; 40(2):135-41. PubMed ID: 6161843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationships of aging changes in the basal ganglia to manifestations of Huntington's chorea.
    Finch CE
    Ann Neurol; 1980 May; 7(5):406-11. PubMed ID: 6446874
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
    Wang YQ; Bian GL; Bai Y; Cao R; Chen LW
    Neurochem Int; 2008 Sep; 53(3-4):56-62. PubMed ID: 18639597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential transmitter release from nerve terminals isolated from basal ganglia and substantia nigra.
    Hardy JA; de Belleroche JS; Border D; Bradford HF
    J Neurochem; 1980 May; 34(5):1130-9. PubMed ID: 6103020
    [No Abstract]   [Full Text] [Related]  

  • 19. A microiontophoretic study of the action of kainic acid and putative neurotransmitters in the rat mesencephalic trigeminal nucleus.
    De Montigny C; Lund JP
    Neuroscience; 1980; 5(9):1621-8. PubMed ID: 6106912
    [No Abstract]   [Full Text] [Related]  

  • 20. Modifications induced on the amygdaloid paroxysmal activity by entopeduncolar or nigral injection of kainic acid, in the cat.
    Crescimanno G; Benigno A; Raieli V
    Arch Int Physiol Biochim; 1983 Dec; 91(5):399-404. PubMed ID: 6204608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.